PL3209294T3 - Kompozycja farmaceutyczna do stosowania w zwiększaniu trofizmu błony śluzowej nosa - Google Patents

Kompozycja farmaceutyczna do stosowania w zwiększaniu trofizmu błony śluzowej nosa

Info

Publication number
PL3209294T3
PL3209294T3 PL15783971T PL15783971T PL3209294T3 PL 3209294 T3 PL3209294 T3 PL 3209294T3 PL 15783971 T PL15783971 T PL 15783971T PL 15783971 T PL15783971 T PL 15783971T PL 3209294 T3 PL3209294 T3 PL 3209294T3
Authority
PL
Poland
Prior art keywords
trophism
increasing
pharmaceutical composition
nasal mucosa
mucosa
Prior art date
Application number
PL15783971T
Other languages
English (en)
Inventor
Giorgio Panin
Domenico TESTA
Germano GUERRA
Original Assignee
Bio.Lo.Ga. S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51951918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3209294(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio.Lo.Ga. S.R.L. filed Critical Bio.Lo.Ga. S.R.L.
Publication of PL3209294T3 publication Critical patent/PL3209294T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15783971T 2014-10-22 2015-10-02 Kompozycja farmaceutyczna do stosowania w zwiększaniu trofizmu błony śluzowej nosa PL3209294T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20141819 2014-10-22
EP15783971.3A EP3209294B1 (en) 2014-10-22 2015-10-02 Pharmaceutical composition for use in increasing the trophism of nasal mucosa
PCT/EP2015/072796 WO2016062522A1 (en) 2014-10-22 2015-10-02 Pharmaceutical composition for use in increasing the trophism of nasal mucosa

Publications (1)

Publication Number Publication Date
PL3209294T3 true PL3209294T3 (pl) 2020-01-31

Family

ID=51951918

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15783971T PL3209294T3 (pl) 2014-10-22 2015-10-02 Kompozycja farmaceutyczna do stosowania w zwiększaniu trofizmu błony śluzowej nosa

Country Status (20)

Country Link
US (1) US10226444B2 (pl)
EP (1) EP3209294B1 (pl)
CN (1) CN107438429A (pl)
AU (1) AU2015335204B2 (pl)
CA (1) CA2965184A1 (pl)
CL (1) CL2017000971A1 (pl)
CY (1) CY1122289T1 (pl)
DK (1) DK3209294T3 (pl)
EA (1) EA033078B1 (pl)
ES (1) ES2757349T3 (pl)
GE (1) GEP20186863B (pl)
HR (1) HRP20191989T1 (pl)
HU (1) HUE047203T2 (pl)
LT (1) LT3209294T (pl)
MX (1) MX2017005195A (pl)
PL (1) PL3209294T3 (pl)
PT (1) PT3209294T (pl)
RS (1) RS59496B1 (pl)
SI (1) SI3209294T1 (pl)
WO (1) WO2016062522A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6992057B2 (ja) 2016-06-10 2022-01-13 クラリティ コスメティックス インコーポレイテッド 非面皰形成性の毛髪および頭皮ケア製剤ならびにその使用方法
IT201700047210A1 (it) * 2017-05-02 2018-11-02 St Ganassini Spa Di Ricerche Biochimiche Composizione cosmetica e/o dermatologica, e suoi usi in campo cosmetico e nel trattamento coadiuvante di patologie dermatologiche
IT201900003515A1 (it) * 2019-03-11 2020-09-11 Gilas Sas Di Carcano Maria Grazia E C COMPOSIZIONE DERMO-COSMETICA PER USO TOPICO, A BASE DI VITAMINA E e/o SUOI ESTERI
IT202100013898A1 (it) * 2021-05-27 2022-11-27 Hulka S R L Composizione comprendente un estere di alfa-tocoferolo per la riduzione del rischio di parto pretermine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US20100055152A1 (en) 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
ITMI981586A1 (it) * 1998-07-10 2000-01-10 Giorgio Panin Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
IT1393056B1 (it) * 2008-09-22 2012-04-11 Bio Lo Ga Srl Uso di vitamina e o suoi derivati per il controllo di artropodi
JP6499446B2 (ja) 2011-06-24 2019-04-10 エピットジェネシス・インコーポレーテッド 抗原特異的免疫モジュレーターとして選択担体、ビタミン、タンニンおよびフラボノイドの組み合わせを含有する医薬組成物
FR2981273B1 (fr) * 2011-10-14 2013-12-20 Gilles Andre Yves Bhat Nouvelle composition pour les muqueuses: tocopherol, macerat huileux de fleurs de calendula dans de l'huile de rose musquee, palmitate de retinol, ubiquinone, ascorbyl palmitate et lactobacillus

Also Published As

Publication number Publication date
LT3209294T (lt) 2019-10-25
AU2015335204A1 (en) 2017-04-13
EP3209294B1 (en) 2019-08-21
GEP20186863B (en) 2018-06-11
MX2017005195A (es) 2017-10-04
ES2757349T3 (es) 2020-04-29
US20170290799A1 (en) 2017-10-12
CN107438429A (zh) 2017-12-05
EP3209294A1 (en) 2017-08-30
EA201790447A1 (ru) 2017-09-29
BR112017008070A2 (pt) 2018-02-20
HRP20191989T1 (hr) 2020-02-07
SI3209294T1 (sl) 2019-12-31
CA2965184A1 (en) 2016-04-28
US10226444B2 (en) 2019-03-12
RS59496B1 (sr) 2019-12-31
BR112017008070A8 (pt) 2022-07-05
HUE047203T2 (hu) 2020-04-28
CY1122289T1 (el) 2021-01-27
EA033078B1 (ru) 2019-08-30
AU2015335204B2 (en) 2020-10-08
CL2017000971A1 (es) 2018-01-12
PT3209294T (pt) 2019-10-08
WO2016062522A1 (en) 2016-04-28
DK3209294T3 (da) 2019-10-28

Similar Documents

Publication Publication Date Title
IL250752A0 (en) Device with compounds for conduction to lungs, oral mucosa and brain
IL282481A (en) A liquid pharmaceutical preparation
IL277241A (en) A liquid pharmaceutical preparation
HK1257026A1 (zh) 液體藥物組合物
EP3190886C0 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF ACUTE RESPIRATORY FAILURE
HK1245086A1 (zh) 處方藥物組成及其製備和使用
HK1245085A1 (zh) 處方藥物組成及其製備和使用
LT3209294T (lt) Farmacinė kompozicija, skirta panaudoti nosies gleivinės trofizmo padidinimui
GB201406172D0 (en) Therapy and pharmaceutical composition
HK1244685A1 (zh) 液體藥物組合物
ZA201608785B (en) Nasal administration
PL3369429T3 (pl) Kompozycja farmaceutyczna przeznaczona do podawania na błonę śluzową nosa
SG11201608123VA (en) Pharmaceutical composition for external use
SG11201608124XA (en) Pharmaceutical composition for external use
ZA201408464B (en) Composition for the use in treatment of asthma
ZA201509174B (en) An oral medicinal composition
SG11201608122PA (en) Pharmaceutical composition for external use